Evidence map›Paper›PMID 39407203›Full record

ArticleBMC medicine2024

Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China.

Yanhua Song, Wei Shu, Yi Pei, Juan Du, Guihui Wu, Hua Wang, Fengling Mi, Fangchao Liu, Liping Ma, Li Xie and 23 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Yanhua Song *Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Wei Shu *Clinical Center On TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Yi Pei *Department of Tuberculosis, Changsha Central Hospital, Changsha, China.
Juan Du *Department of Tuberculosis, Wuhan Pulmonary Hospital, Wuhan, China.
Guihui Wu *Department of Tuberculosis, Chengdu Public Health Clinical Center, Chengdu, China.
Hua Wang *Department of Tuberculosis, Anhui Chest Hospital, Hefei, China.
Fengling MiScience and Technology Office, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Fangchao LiuScience and Technology Office, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China.
Liping MaDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Li XieDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Zhongshun KongDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Xiaoguang WuDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Rongmei LiuDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Hongmei ChenDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Hua LiDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Qiping GeDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Lihui NieDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Zizheng LvDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Xuerui HuangDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Mingwu LiDepartment of Tuberculosis, The Third People's Hospital of Kunming, Kunming, China.
Mingying JiangDepartment of Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China.
Xiaohong ChenDepartment of Tuberculosis, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China.
Qingshan CaiDepartment of Tuberculosis, Hangzhou Red Cross Hospital, Hangzhou, China.
Wei ChenDepartment of Tuberculosis, Shenyang Tenth People's Hospital, Shenyang, China.
Yanmei LiuDepartment of Tuberculosis, Tuberculosis Hospital of Jilin Province, Changchun, China.
Yanfang MiaoDepartment of Tuberculosis, The Forth People's Hospital of Taiyuan, Taiyuan, China.
Yan TangDepartment of Tuberculosis, Shaanxi Provincial Tuberculosis Prevention and Control Hospital, Xian, China.
Yu ChenDepartment of Tuberculosis, Henan Provincial Infectious Diseases Hospital, Zhengzhou, China.
Shujun GengDepartment of Tuberculosis, Hebei Chest Hospital, Shijiazhuang, China.
Quanying ZhouDepartment of Tuberculosis, Lanzhou Pulmonary Hospital, Lanzhou, China.
Yuhong LiuClinical Center On TB, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Yu PangDepartment of Bacteriology and Immunology, Beijing Key Laboratory On Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/ /Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China. pangyupound@163.com.
Mengqiu GaoDepartment of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China. gaomqwdm@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39407203
PMCPMC11476063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.